Advanced search
Publication Cover
Clinical Ophthalmology Volume 15, 2021 - Issue
Submit an article Journal homepage
104
Views
2
CrossRef citations to date
0
Altmetric
Clinical Trial Report

Pars Plana Vitrectomy with Internal Limiting Membrane Peeling for Treatment-Naïve Diabetic Macular Edema: A Prospective, Uncontrolled Pilot Study

Ryan B Rush1 Instituto de la Visión– Hospital La Carlota, Montemorelos, Nuevo León, 67530, México;2 Panhandle Eye Group, Amarillo, TX, 79106, USA;3 Department of Surgery, Texas Tech University Health Science Center, Amarillo, TX, 79106, USA;4 Southwest Retina Specialists, Amarillo, TX, 79106, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-2790-6155View further author information
ORCID Icon &
Sloan W Rush2 Panhandle Eye Group, Amarillo, TX, 79106, USA;3 Department of Surgery, Texas Tech University Health Science Center, Amarillo, TX, 79106, USAView further author information
Pages 2619-2624 | Published online: 21 Jun 2021

References

  • Varma R, Bressler NM, Doan QV, et al. Prevalence of and risk factors for diabetic macular edema in the United States. JAMA Ophthalmol. 2014;132(11):1334–1340. doi:10.1001/jamaophthalmol.2014.2854
  • Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. Photocoagulation for diabetic macular edema. Arch Ophthalmol. 1985;103(12):1796–1806. doi:10.1001/archopht.1985.01050120030015
  • Lam DS, Chan CK, Mohamed S, et al. Intravitreal triamcinolone plus sequential grid laser versus triamcinolone or laser alone for treating diabetic macular edema: six-month outcomes. Ophthalmology. 2007;114(12):2162–2167. doi:10.1016/j.ophtha.2007.02.006
  • Wells JA, Glassman AR, Ayala AR, et al.; Diabetic Retinopathy Clinical Research Network. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med. 2015;372:1193–1203.
  • Nakajima T, Roggia MF, Noda Y, et al. Effect of internal limiting membrane peeling during vitrectomy for diabetic macular edema: systematic Review and meta-analysis. Retina. 2015;35(9):1719–1725. doi:10.1097/IAE.0000000000000622
  • Simunovic MP, Hunyor AP, Ho IV. Vitrectomy for diabetic macular edema: a systematic review and meta-analysis. Can J Ophthalmol. 2014;49(2):188–195. doi:10.1016/j.jcjo.2013.11.012
  • Lewis H, Abrams GW, Blumenkranz MS, et al. Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction. Ophthalmology. 1992;99(5):753–759. doi:10.1016/S0161-6420(92)31901-3
  • Yamamoto T, Akabane N, Takeuchi S. Vitrectomy for diabetic macular edema: the role of posterior vitreous detachment and epimacular membrane. Am J Ophthalmol. 2001;132(3):369–377. doi:10.1016/S0002-9394(01)01050-9
  • Haller JA, Qin H, Flaxel CJ, et al. Diabetic retinopathy clinical research network writing committee. Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction. Ophthalmology. 2010;117:1087–1093.
  • Kumagai K, Furukawa M, Ogino N, et al. Long-term follow-up of vitrectomy for diffuse nontractional diabetic macular edema. Retina. 2009;29(4):464–472. doi:10.1097/IAE.0b013e31819c632f
  • Harbour JW, Smiddy WE, Flynn HW Jr, et al. Vitrectomy for diabetic macular edema associated with a thickened and taut posterior hyaloid membrane. Am J Ophthalmol. 1996;121(4):405–413. doi:10.1016/S0002-9394(14)70437-4
  • Nasrallah FP, Jalkh AE, Van Coppenolle F, et al. The role of the vitreous in diabetic macular edema. Ophthalmology. 1988;95(10):1335–1339. doi:10.1016/S0161-6420(88)33004-6
  • Laidlaw DA. Vitrectomy for diabetic macular oedema. Eye (Lond). 2008;22(10):1337–1341. doi:10.1038/eye.2008.84
  • Hoerauf H, Bruggemann A, Muecke M, et al. Pars plana vitrectomy for diabetic macular edema. Internal limiting membrane delamination vs posterior hyaloid removal. A prospective randomized trial. Graefes Arch Clin Exp Ophthalmol. 2011;249(7):997–1008. doi:10.1007/s00417-010-1610-8
  • Nguyen QD, Brown DM, Marcus DM, et al. Ranibizumab for diabetic macular edema: results from 2 Phase III randomized trials: RISE and RIDE. Ophthalmology. 2012;119(4):789–801. doi:10.1016/j.ophtha.2011.12.039
  • Korobelnik JF, Do DV, Schmidt-Erfurth U, et al. Intravitreal aflibercept for diabetic macular edema. Ophthalmology. 2014;121(11):2247–2254. doi:10.1016/j.ophtha.2014.05.006
  • Wells JA, Glassman AR, Ayala AR, et al. Diabetic retinopathy clinical research network. Aflibercept, bevacizumab or ranibizumab for diabetic macular edema. N Engl J Med. 2015;372:1193–1203.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.